ConductScience.org, home

Paper5115909

Mouse myeloma tumor stem cells: a primary cell culture assay.

Park CH and 2 others. J Natl Cancer Inst, 1971. Cited by 315 papers, by iCite.

Cite this record

ConductScience Library. Mouse myeloma tumor stem cells: a primary cell culture assay. Papers, record 5115909. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5115909

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mouse myeloma tumor stem cells: a primary cell culture assay.
PubMed
Journal
J Natl Cancer Inst
PubMed
Year
1971
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
315
iCite
Relative citation ratio, by iCite
4.64
iCite
Revised in PubMed
2022-03-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Park CHC H
2Bergsagel DED E
3McCulloch EAE A

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CellsMajor topic
Culture TechniquesMajor topic
MitosisMajor topic
PlasmacytomaMajor topic
Animals
Cell Count
Centrifugation
Culture Media
Hematopoietic Stem Cells
Injections
Karyotyping
Kidney Tubules
Methods
Mice
Mice, Inbred Strains
Neoplasm Transplantation
Spleen

Source PubMed

Download CSV of topics

Cited by116

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 315 citations.

PMIDTitleJournalYearIn PapersSource
39446925Epstein-Barr virus reactivation induces divergent abortive, reprogrammed, and host shutoff states by lytic progression.PLoS Pathog2024https://conductscience.org/library/papers/39446925PubMed
38965243Cancer stem cells: advances in knowledge and implications for cancer therapy.Signal Transduct Target Ther2024https://conductscience.org/library/papers/38965243PubMed
38915538Epstein-Barr virus reactivation induces divergent abortive, reprogrammed, and host shutoff states by lytic progression.bioRxiv2024https://conductscience.org/library/papers/38915538PubMed
37566052DCUN1D1 Is an Essential Regulator of Prostate Cancer Proliferation and Tumour Growth That Acts through Neddylation of Cullin 1, 3, 4A and 5 and Deregulation of Wnt/Catenin Pathway.Cells2023https://conductscience.org/library/papers/37566052PubMed
36648606Cancer Stem Cells are Actually Stem Cells with Disordered Differentiation: the Monophyletic Origin of Cancer.Stem Cell Rev Rep2023https://conductscience.org/library/papers/36648606PubMed
36338705Heterogeneity of glioblastoma stem cells in the context of the immune microenvironment and geospatial organization.Front Oncol2022https://conductscience.org/library/papers/36338705PubMed
35483929Human acute myeloid leukemia stem cells: evolution of concept.Blood Res2022https://conductscience.org/library/papers/35483929PubMed
34697469Analysis of clonogenic growth in vitro.Nat Protoc2021https://conductscience.org/library/papers/34697469PubMed
34693187From the niche to malignant hematopoiesis and back: reciprocal interactions between leukemia and the bone marrow microenvironment.JBMR Plus2021https://conductscience.org/library/papers/34693187PubMed
33959299Targeting Cancer Stem Cells-A Renewed Therapeutic Paradigm.Oncol Hematol Rev2017https://conductscience.org/library/papers/33959299PubMed
33644055
A Mechanism Leading to Changes in Copy Number Variations Affected by Transcriptional Level Might Be Involved in Evolution, Embryonic Development, Senescence, and Oncogenesis Mediated by Retrotransposons.
Front Cell Dev Biol2021https://conductscience.org/library/papers/33644055PubMed
32684928Clinical Impact of Breast Cancer Stem Cells in Metastatic Breast Cancer Patients.J Oncol2020https://conductscience.org/library/papers/32684928PubMed
32050631Multiple Myeloma: Available Therapies and Causes of Drug Resistance.Cancers (Basel)2020https://conductscience.org/library/papers/32050631PubMed
31700218Head and neck cancer management and cancer stem cells implication.Saudi Dent J2019https://conductscience.org/library/papers/31700218PubMed
31426611Cancer Stem Cells and Targeting Strategies.Cells2019https://conductscience.org/library/papers/31426611PubMed
30613312Cancer stem cell impact on clinical oncology.World J Stem Cells2018https://conductscience.org/library/papers/30613312PubMed
29133573The RARS-MAD1L1 Fusion Gene Induces Cancer Stem Cell-like Properties and Therapeutic Resistance in Nasopharyngeal Carcinoma.Clin Cancer Res2018https://conductscience.org/library/papers/29133573PubMed
28855316Stem/progenitor cells in pituitary organ homeostasis and tumourigenesis.J Endocrinol2018https://conductscience.org/library/papers/28855316PubMed
28624993Cancer stem cell marker glycosylation: Nature, function and significance.Glycoconj J2017https://conductscience.org/library/papers/28624993PubMed
28454446Lentivirus-mediated RNA interference of tripartite motif 68 inhibits the proliferation of colorectal cancer cell lines SW1116 and HCT116 in vitro.Oncol Lett2017https://conductscience.org/library/papers/28454446PubMed

See all 116 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5115909

GET https://conductscience.org/api/papers/v1/5115909/cited_by?page=2